With a stock price of $4.64, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) is among the 8 Best Up and Coming Penny Stocks to Buy Now.
On May 19, Alliance Global initiated coverage of NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) with a Buy rating and a $13 price target
The firm highlighted the company’s focus on developing intranasally delivered small-molecule therapies for aggressive brain cancers, including glioma and glioblastoma. According to the analyst, both of NeOnc’s lead candidates feature differentiated safety profiles and novel delivery mechanisms that may help overcome some of the limitations associated with traditional brain cancer treatments, positioning the company to benefit from anticipated growth in the market as new therapies emerge. A day earlier, Maxim initiated coverage of NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) with a Buy rating and a $20 price target.
The second bullish initiation from a major research firm further underscores growing confidence in the company’s pipeline and proprietary drug-delivery platform, while suggesting significant potential upside from current levels as development programs advance. NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) is a clinical-stage biopharmaceutical company focused on developing targeted therapies and innovative delivery methods for central nervous system diseases, particularly brain cancer. Its proprietary NEO platform is designed to transport therapeutics across the blood-brain barrier, one of the most significant challenges in neurological drug development.